Biotechnology & Biologics
Don’t Navigate Complex Science Alone
Partner with Our Legal Pioneers
TALG stands as a pillar of support and expertise in the realm of biotechnology law. Our team’s extensive academic training in specialized biotechnology disciplines, coupled with years of hands-on experience, positions us as industry leaders. We possess a unique understanding of the nuanced needs of embryonic biotechnology firms seeking access to capital markets, while also adeptly navigating the intricate FDA compliance process.
We have successfully represented large biotechnology and publicly traded biologics companies, lending our invaluable insights and legal prowess. Our comprehensive services encompass critical areas such as Advertising & Labeling issues (FDA & FTC), ensuring your compliance and safeguarding your brand’s reputation. With our deep expertise in Biotechnology capital markets, Biotechnology governance and regulatory issues, and FDA compliance and registration, we are your trusted partner in the ever-evolving biotech landscape. Don’t make the mistake of navigating these complexities alone; choose TALG to secure your biotech venture’s success.
Leveraging considerable academic training in specialized biotechnology disciplines, together with years of practical experience has enabled TALG to be one of the leaders in biotechnology law. We have a unique understanding of the needs of embryonic biotechnology firms with promising technology and the need for access to capital markets, while efficiently navigating the complex FDA compliance process. Moreover, we’ve represented larger biotechnology and publicly traded biologics companies for over 10 years. We’ve also assisted our clients with Advertising & Labeling issues (FDA & FTC) among other services.
- Biotechnology capital markets
- Biotechnology governance and regulatory issues
- FDA compliance and registration
Biotechnology Attorneys
Your Compliance and Growth Partners
As industry leaders, we bring a unique understanding of the intricate needs of emerging biotechnology firms, particularly their capital market aspirations, and the complexities of FDA compliance. With over a decade of successful representation of larger biotech companies, we provide invaluable insights and legal counsel. Our comprehensive services, including expertise in Biotechnology capital markets, Biotechnology governance and regulatory issues, and FDA compliance and registration, empower our clients to navigate the multifaceted biotech landscape with confidence. Partner with us to unlock your biotech venture’s full potential and ensure compliance with the highest standards of excellence.
From Our Clients
Recent Biotechnology News
The FDA announced the new Center for Clinical Trial Innovation to serve as a central hub to support innovative approaches to clinical trials.
Clinical trials are essential for healthcare decisions. Poorly designed trials risk the safety of participants and produce unreliable data.
The FDA’s Center for Drug Evaluation and Research (CDER) issued a discussion paper on the role of Artificial Intelligence.
Biotech and life-science companies are often in need of appropriate capital to execute the company’s mission.